MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

29 Oct 2024 Evaluate
A minor change in the total revenue was seen in the September 2024 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.An average growth of 38.86% was recorded for the quarter ended September 2024 to Rs. 6.11  millions from Rs. 4.40 millions.Operating profit surged to 6.12 millions from the corresponding previous quarter of 4.42 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 6.31 4.60 37.17 9.33 8.89 4.95 18.38 2.95 523.05
PBIDT 6.12 4.42 38.46 8.61 8.20 5.00 16.52 0.86 1820.93
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 6.12 4.42 38.46 8.61 8.20 5.00 16.52 0.86 1820.93
Depreciation 0.01 0.02 -50.00 0.02 0.04 -50.00 0.08 0.13 -38.46
PBT 6.11 4.40 38.86 8.59 8.16 5.27 16.44 0.73 2152.05
TAX 0.00 0.00 0.00 0.00 0.00 0.00 4.43 0.26 1603.85
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.69 -1.04 -262.50
PAT 6.11 4.40 38.86 8.59 8.16 5.27 12.01 0.47 2455.32
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..